Novel Tip-Loaded Dissolving and Implantable Microneedle Array Patches for Sustained Release of Finasteride
July 2021
in “
International Journal of Pharmaceutics
”
finasteride androgenic alopecia microneedle array patches benign prostatic hyperplasia oral administration drug absorption side effects non-invasive delivery long-acting delivery polymers drug loading capacity mechanical resistance in vitro release sustained drug release Propecia microneedle patches BPH oral finasteride non-invasive long-acting drug capacity mechanical strength in vitro sustained release
Studysummary This study describes the development of microneedle array patches for finasteride that released the drug over 7 to 14 days in vitro, suggesting a potential alternative to oral treatments for long-term management of benign prostatic hyperplasia and androgenic alopecia.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on sciencedirect.com →